The treatment made, has failed its main goal to treat Covid-19 in exposed patients. Covid-19 vaccine maker AstraZeneca on Tuesday revealed it had hit a setback in trials of a treatment for the Covid-19. The drug, made from a combination of two antibodies, failed its main goal to treat Covid-19 symptoms in exposed patients, AstraZeneca said in a statement. The company is nevertheless continuing trials to assess whether the drug can prevent Covid or treat more severe symptoms. Meanwhile, AstraZeneca's Covid-19 vaccine, which was developed with the University of Oxford, continues to face safety doubts.

Source: News 24 June 15, 2021 12:22 UTC